» Articles » PMID: 23776618

TUSC1, a Putative Tumor Suppressor Gene, Reduces Tumor Cell Growth in Vitro and Tumor Growth in Vivo

Overview
Journal PLoS One
Date 2013 Jun 19
PMID 23776618
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

We previously reported the identification of TUSC1 (Tumor Suppressor Candidate 1), as a novel intronless gene isolated from a region of homozygous deletion at D9S126 on chromosome 9p in human lung cancer. In this study, we examine the differential expression of TUSC1 in human lung cancer cell lines by western blot and in a primary human lung cancer tissue microarray by immunohistochemical analysis. We also tested the functional activities and mechanisms of TUSC1 as a tumor suppressor gene through growth suppression in vitro and in vivo. The results showed no expression of TUSC1 in TUSC1 homozygously deleted cells and diminished expression in some tumor cell lines without TUSC1 deletion. Interestingly, the results from a primary human lung cancer tissue microarray suggested that higher expression of TUSC1 was correlated with increased survival times for lung cancer patients. Our data demonstrated that growth curves of tumor cell lines transfected with TUSC1 grew slower in vitro than those transfected with the empty vector. More importantly, xenograph tumors in nude mice grew significantly slower in vivo in cells stably transfected with TUSC1 than those transfected with empty vector. In addition, results from confocal microscopy and immunohistochemical analyses show distribution of TUSC1 in the cytoplasm and nucleus in tumor cell lines and in normal and tumor cells in the lung cancer tissue microarray. Taken together, our results support TUSC1 has tumor suppressor activity as a candidate tumor suppressor gene located on chromosome 9p.

Citing Articles

A Mouse Systems Genetics Approach Reveals Common and Uncommon Genetic Modifiers of Hepatic Lysosomal Enzyme Activities and Glycosphingolipids.

Duran A, Priestman D, Heras M, Rebolledo-Jaramillo B, Olguin V, Calderon J Int J Mol Sci. 2023; 24(5).

PMID: 36902345 PMC: 10002577. DOI: 10.3390/ijms24054915.


Automatic Text-Mining Approach to Identify Molecular Target Candidates Associated with Metabolic Processes for Myotonic Dystrophy Type 1.

Kuntawala D, Martins F, Vitorino R, Rebelo S Int J Environ Res Public Health. 2023; 20(3).

PMID: 36767649 PMC: 9915907. DOI: 10.3390/ijerph20032283.


Utilization of Cancer Cell Line Screening to Elucidate the Anticancer Activity and Biological Pathways Related to the Ruthenium-Based Therapeutic BOLD-100.

Park B, Raha P, Pankovich J, Bazett M Cancers (Basel). 2023; 15(1).

PMID: 36612025 PMC: 9817855. DOI: 10.3390/cancers15010028.


Prognostic Signature GXYLT2 Is Correlated with Immune Infiltration in Bladder Cancer.

Wu S, Qiu S, Chen W, Ding L, Wu L Dis Markers. 2022; 2022:5081413.

PMID: 36263004 PMC: 9576427. DOI: 10.1155/2022/5081413.


Coronary artery disease and cancer: a significant resemblance.

Rakshit S, Shanmugam G, Sarkar K Med Oncol. 2022; 39(12):187.

PMID: 36071253 DOI: 10.1007/s12032-022-01789-7.


References
1.
Shan Z, Parker T, Wiest J . Identifying novel homozygous deletions by microsatellite analysis and characterization of tumor suppressor candidate 1 gene, TUSC1, on chromosome 9p in human lung cancer. Oncogene. 2004; 23(39):6612-20. PMC: 3449089. DOI: 10.1038/sj.onc.1207857. View

2.
Pollock P, Welch J, Hayward N . Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development. Cancer Res. 2001; 61(3):1154-61. View

3.
Xiao S, Li D, Corson J, Vijg J, Fletcher J . Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Cancer Res. 1995; 55(14):2968-71. View

4.
Yang X, Liang X, Pfeiffer R, Wheeler W, Maeder D, Burdette L . Associations of 9p21 variants with cutaneous malignant melanoma, nevi, and pigmentation phenotypes in melanoma-prone families with and without CDKN2A mutations. Fam Cancer. 2010; 9(4):625-33. PMC: 3233727. DOI: 10.1007/s10689-010-9356-3. View

5.
Parsons D, Jones S, Zhang X, Cheng-Ho Lin J, Leary R, Angenendt P . An integrated genomic analysis of human glioblastoma multiforme. Science. 2008; 321(5897):1807-12. PMC: 2820389. DOI: 10.1126/science.1164382. View